利妥昔单抗和克拉屈滨成功治疗的毛细胞白血病患者出现多灶性脑受累
Multifocal brain involvement in a patient with hairy cell leukemia successfully treated with rituximab and cladribine.
作者信息
Perry Anamarija M, Matsuda Kant, Wadhwa Vikram, Hewitt Donna, Almiski Muhamad, Johnston James B, Banerji Versha
机构信息
Department of Pathology and.
Department of Radiology, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
出版信息
Blood Adv. 2017 May 30;1(14):899-902. doi: 10.1182/bloodadvances.2017004697. eCollection 2017 Jun 13.
Abstract
Brain involvement, although rare, can occur in HCL.The combination of cladribine and rituximab is a highly effective treatment of HCL with brain involvement.
摘要
脑受累在毛细胞白血病（HCL）中虽罕见，但仍可能发生。克拉屈滨与利妥昔单抗联合使用是治疗脑受累HCL的一种高效疗法。
相似文献
1
Multifocal brain involvement in a patient with hairy cell leukemia successfully treated with rituximab and cladribine.利妥昔单抗和克拉屈滨成功治疗的毛细胞白血病患者出现多灶性脑受累
Blood Adv. 2017 May 30;1(14):899-902. doi: 10.1182/bloodadvances.2017004697. eCollection 2017 Jun 13.
2
Long-term durable remission by cladribine followed by rituximab in patients with hairy cell leukaemia: update of a phase II trial.毛细胞白血病患者接受克拉屈滨序贯利妥昔单抗治疗后的长期持久缓解：一项II期试验的更新
Br J Haematol. 2016 Sep;174(5):760-6. doi: 10.1111/bjh.14129. Epub 2016 Jun 15.
3
Rituximab in the treatment of the variant of hairy cell leukaemia: a case report.利妥昔单抗治疗毛细胞白血病变异型：一例报告
Prilozi. 2008 Dec;29(2):355-60.
4
Atypical meningeal localization of classical hairy cell leukemia with an impressive response to rituximab and cladribine association. A case report and literature review.经典型毛细胞白血病的非典型脑膜定位对利妥昔单抗和克拉屈滨联合治疗反应显著。一例病例报告及文献综述
EJHaem. 2024 Jan 9;5(1):242-246. doi: 10.1002/jha2.841. eCollection 2024 Feb.
5
Cost-effectiveness of pentostatin compared with cladribine in the management of hairy cell leukemia in the United Kingdom.在英国，与克拉屈滨相比，喷司他丁治疗毛细胞白血病的成本效益分析。
Clin Ther. 2009;31 Pt 2:2398-415. doi: 10.1016/j.clinthera.2009.11.016.
6
Multiply relapsing hairy cell leukemia responsive to repeated courses of rituximab: a case report.对利妥昔单抗重复疗程有反应的多次复发毛细胞白血病：一例报告
Hematology. 2006 Aug;11(4):267-70. doi: 10.1080/10245330600841600.
7
Chemoimmunotherapy for hairy cell leukemia.毛细胞白血病的化学免疫疗法。
Best Pract Res Clin Haematol. 2015 Dec;28(4):230-5. doi: 10.1016/j.beha.2015.09.005. Epub 2015 Oct 8.
8
Cladribine in hairy cell leukemia.克拉屈滨治疗毛细胞白血病
Hematol Oncol Clin North Am. 2006 Oct;20(5):1109-23. doi: 10.1016/j.hoc.2006.06.008.
9
The role of rituximab in combination with pentostatin or cladribine for the treatment of recurrent/refractory hairy cell leukemia.利妥昔单抗联合喷司他丁或克拉屈滨治疗复发/难治性毛细胞白血病的作用
Cancer. 2007 Nov 15;110(10):2240-7. doi: 10.1002/cncr.23032.
10
[Successful use of cladribine in the treatment of an elderly woman with typical hairy cell leukemia].[克拉屈滨成功用于治疗一名老年典型毛细胞白血病女性患者]
Gan To Kagaku Ryoho. 2007 Nov;34(11):1885-8.
引用本文的文献
1
Rare Clinical Symptoms in Hairy Cell Leukemia: An Overview.毛细胞白血病的罕见临床症状：概述
Cancers (Basel). 2024 Sep 1;16(17):3054. doi: 10.3390/cancers16173054.
2
Recommendations for the Management of Patients with Hairy-Cell Leukemia and Hairy-Cell Leukemia-like Disorders: A Work by French-Speaking Experts and French Innovative Leukemia Organization (FILO) Group.毛细胞白血病和毛细胞白血病样疾病患者的管理建议：由法语专家和法国创新白血病组织（FILO）小组完成的一项工作
Cancers (Basel). 2024 Jun 10;16(12):2185. doi: 10.3390/cancers16122185.
3
Case report: A case of classic hairy cell leukemia with CNS involvement treated with vemurafenib.病例报告：1例中枢神经系统受累的经典毛细胞白血病患者接受维莫非尼治疗。
Front Oncol. 2023 Jan 12;12:1100577. doi: 10.3389/fonc.2022.1100577. eCollection 2022.
4
Hairy Cell Leukaemia.毛细胞白血病。
Curr Oncol Rep. 2020 Apr 16;22(5):42. doi: 10.1007/s11912-020-00911-0.
本文引用的文献
1
Response of relapsed central nervous system hairy cell leukemia to vemurafenib.复发的中枢神经系统毛细胞白血病对维莫非尼的反应。
Leuk Lymphoma. 2016 Dec;57(12):2952-2954. doi: 10.1080/10428194.2016.1177773. Epub 2016 Apr 27.
2
Interesting case of lymphocytosis and splenomegaly.淋巴细胞增多和脾肿大的有趣病例。
BMJ. 2016 Mar 3;352:i1227. doi: 10.1136/bmj.i1227.
3
Clinical features and diagnosis of hairy cell leukemia.毛细胞白血病的临床特征与诊断
Best Pract Res Clin Haematol. 2015 Dec;28(4):180-92. doi: 10.1016/j.beha.2015.10.017. Epub 2015 Oct 26.
4
Cladribine with immediate rituximab for the treatment of patients with variant hairy cell leukemia.克拉屈滨联合利妥昔单抗治疗变异型毛细胞白血病患者。
Clin Cancer Res. 2013 Dec 15;19(24):6873-81. doi: 10.1158/1078-0432.CCR-13-1752. Epub 2013 Nov 25.
5
Rare case of hairy cell leukemia with brain parenchymal involvement: a diagnostic dilemma.毛细胞白血病累及脑实质的罕见病例：诊断困境
J Clin Oncol. 2013 Apr 10;31(11):e186-8. doi: 10.1200/JCO.2012.44.8787. Epub 2013 Feb 25.
6
Melanoma brain metastases and vemurafenib: need for further investigation.黑色素瘤脑转移和维莫非尼：需要进一步研究。
Mayo Clin Proc. 2012 Oct;87(10):976-81. doi: 10.1016/j.mayocp.2012.07.006.
7
Phase 2 study of cladribine followed by rituximab in patients with hairy cell leukemia.克拉屈滨序贯利妥昔单抗治疗慢性淋巴细胞白血病的Ⅱ期临床研究
Blood. 2011 Oct 6;118(14):3818-23. doi: 10.1182/blood-2011-04-351502. Epub 2011 Aug 5.
8
Rituximab monotherapy for patients with recurrent primary CNS lymphoma.利妥昔单抗单药治疗复发性原发性中枢神经系统淋巴瘤患者。
Neurology. 2011 Mar 8;76(10):929-30. doi: 10.1212/WNL.0b013e31820f2d94.
9
The role of rituximab in combination with pentostatin or cladribine for the treatment of recurrent/refractory hairy cell leukemia.利妥昔单抗联合喷司他丁或克拉屈滨治疗复发/难治性毛细胞白血病的作用
Cancer. 2007 Nov 15;110(10):2240-7. doi: 10.1002/cncr.23032.
10
Cryptococcus neoformans meningitis in a patient with hairy cell leukemia.毛细胞白血病患者的新型隐球菌性脑膜炎
Am J Hematol. 2006 May;81(5):387. doi: 10.1002/ajh.20618.
Zotero 插件